Study protocol: mycophenolate mofetil as maintenance therapy after rituximab treatment for childhood-onset, complicated, frequently-relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicenter double-blind, randomized, placebo-controlled trial (JSKDC07).
Tomoko HorinouchiMayumi SakoKoichi NakanishiKenji IshikuraShuichi ItoHidefumi NakamuraMari Saito ObaKandai NozuKazumoto IijimaPublished in: BMC nephrology (2018)
This trial was prospectively registered to UMIN Clinical Trials Registry on June 23, 2014 (UMIN Trial ID: UMIN000014347 ).